PBDs also show efficacy against both dividing and non-dividing cells, and recent studies suggest CD276 is also expressed by cancer stem cells, which are not always dividing.58,59 Despite these advantages, the main concern with PBDs, as with any ADC payload, is their potential for toxicity. This evidence concerns the gene CD276 and cancer.